Valuation: CEREP

Market Cap 75.66M 86.78M 71.26M 64.9M 122M 8.31B 122M 853M 329M 4.23B 326M 319M 13.67B P/E 2024 *
-
P/E 2025 -
Enterprise Value 54.63M 62.65M 51.45M 46.85M 87.85M 6B 87.96M 616M 237M 3.06B 235M 230M 9.87B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 11/04/2024
Director TitleAgeSince
Director/Board Member - -
Chairman - 11/08/2023
Director/Board Member - 23/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%+2.73%+1.03%+28.74% 46.28B
+1.30%+1.58%+44.15%+35.50% 43.85B
+0.95%-6.02%+342.72%+532.41% 40.93B
+4.23%+3.35%+9.35%+94.73% 39.89B
+1.11%+1.45%+11.52%+45.96% 29.5B
+1.94%+4.84%+25.19%+159.21% 17.09B
+0.37%-10.32% - - 15.55B
+2.12%+8.18%+24.78%+41.21% 15.22B
+0.24%+25.43%-11.57% - 14.05B
Average +1.41%+3.23%+55.90%+133.97% 29.15B
Weighted average by Cap. +1.51%+1.71%+70.37%+142.46%

Financials

2024 2025
Net sales 40.49M 46.44M 38.13M 34.73M 65.11M 4.45B 65.19M 457M 176M 2.27B 174M 171M 7.31B 41.1M 47.14M 38.71M 35.25M 66.09M 4.52B 66.18M 464M 179M 2.3B 177M 173M 7.42B
Net income 7.15M 8.21M 6.74M 6.14M 11.51M 786M 11.52M 80.7M 31.1M 400M 30.82M 30.14M 1.29B 4.78M 5.49M 4.5M 4.1M 7.69M 525M 7.7M 53.94M 20.79M 268M 20.6M 20.15M 864M
Net Debt -17.25M -19.79M -16.25M -14.8M -27.75M -1.9B -27.78M -195M -75.01M -966M -74.33M -72.68M -3.12B -21.03M -24.13M -19.81M -18.04M -33.83M -2.31B -33.87M -237M -91.45M -1.18B -90.62M -88.61M -3.8B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!